Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Eli Lilly and Company (LLY)

Vienna
Currency in EUR
755.20
+7.20(+0.96%)
Closed

LLY Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa22,319.524,539.828,318.428,541.434,124.1
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+3.84%+9.95%+15.4%+0.79%+19.56%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa4,721.25,483.36,973.16,629.87,082.2
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa17,598.319,056.521,345.321,911.627,041.9
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+4.68%+8.29%+12.01%+2.65%+23.41%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa78.85%77.66%75.38%76.77%79.25%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa11,598.911,845.713,072.613,258.316,254.6
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+7.54%+2.13%+10.36%+1.42%+22.6%
aa.aaaa.aaaa.aaaa.aaaa.aa5,5955,976.36,930.77,190.89,313.4
aa.aaaa.aaaa.aaaa.aaaa.aa6,003.95,869.46,141.96,067.56,941.2
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa5,999.47,210.88,272.78,653.310,787.3
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-0.44%+20.19%+14.73%+4.6%+24.66%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa26.88%29.38%29.21%30.32%31.61%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-320.2-326.6-314.4-268.8-312.3
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-284.86%-2%+3.74%+14.5%-16.18%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-400.6-359.6-339.8-331.6-485.9
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa80.43325.462.8173.6
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-56.6-195.551.4-14.3-32.7
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa5,622.66,688.78,009.78,370.210,442.3
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa309.8----
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-589.2-749.8-2,018.1-1,130.1-3,822
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa5,265.97,229.96,155.56,806.46,554.6
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+43.09%+37.3%-14.86%+10.57%-3.7%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa23.59%29.46%21.74%23.85%19.21%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa6281,036.2573.8561.61,314.2
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa8,318.46,193.75,581.76,244.85,240.4
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa8,318.46,193.75,581.76,244.85,240.4
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+157.38%-25.54%-9.88%+11.88%-16.08%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa37.27%25.24%19.71%21.88%15.36%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa4,637.96,193.75,581.76,244.85,240.4
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa4.986.826.156.935.82
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+62.49%+36.99%-9.81%+12.53%-15.94%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa4.966.796.126.95.8
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+62.62%+36.9%-9.87%+12.75%-15.94%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa931.06907.63906.96901.74900.18
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa935.68912.51911.68904.62903.28
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa2.582.963.43.924.52
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+14.67%+14.73%+14.86%+15.29%+15.31%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa7,2328,534.79,820.310,175.812,314.6
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-5.28%+18.01%+15.06%+3.62%+21.02%
EBITDA Margin %
aa.aaaa.aa